e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Bronchodilators with and without corticosteroids
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Glucocorticoid-induced neutrophil survival is potentiated by β
2
-agonists
H. Perttunen, E. Moilanen, X. Zhang, H. Kankaanranta (Tampere, Finland)
Source:
Annual Congress 2005 - Bronchodilators with and without corticosteroids
Session:
Bronchodilators with and without corticosteroids
Session type:
Thematic Poster Session
Number:
844
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Perttunen, E. Moilanen, X. Zhang, H. Kankaanranta (Tampere, Finland). Glucocorticoid-induced neutrophil survival is potentiated by β
2
-agonists. Eur Respir J 2005; 26: Suppl. 49, 844
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Glucocorticoid-induced reversal of cytokine-afforded eosinophil survival is mediated via transactivation whereas promotion of neutrophil survival occurs through transrepression
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004
Remifentanil attenuates LPS-induced neutrophil activation
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Roflumilast potently inhibits CXCL1 mediated neutrophil migration in COPD patients
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Inhibition of neutrophil elastase contributes to attenuationof lipopolysaccharide-induced acute lung injuryduring neutropenia recovery in mice
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Dexamethasone potently induces human basophil apoptosis
Source: Eur Respir J 2002; 20: Suppl. 38, 29s
Year: 2002
Inhibition of LPS-induced neutrophil recruitment in the lungs correlates with modulation of neutrophil CD11b expression using the selective CXCR2 receptor antagonist SB-656933
Source: Eur Respir J 2004; 24: Suppl. 48, 218s
Year: 2004
Impaired lung neutrophil clearance causes necrosis and enhanced inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 452s
Year: 2004
Hypoxia induces IL-18 and neutrophil influx in lung parenchyma possibly mediated by MIP-2
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Lung inflammation is significantly reduced by recovery of neutrophil apoptosis in vivo
Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD
Year: 2012
Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
A CXCR2 antagonist inhibits polyI:C-induced airway neutrophil, but not lymphocyte infiltrate
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
GB001 potently inhibits PGD2 metabolite-induced DP2-mediated cell signaling and eosinophil activation
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020
Effect of curcumin on LPS-induced neutrophil activation and acute lung injury
Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation
Year: 2012
Removal of extracellular ATP improves fMLP-induced neutrophil chemotaxis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
Modulation of neutrophil activation and survival by bronchial epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 437s
Year: 2004
Dimethylfumarate reduces growth factor- and cytokine-induced IL-6 release from human lung fibroblasts: role of (NF)-κB
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Regulation of neutrophil function by hypoxia
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004
Ionomycin stimulates a synergistic effect of IL-8 and induced sputum on PMN chemotaxis during COPD
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept